Skip to main content
. 2016 Aug 22;7(38):62377–62385. doi: 10.18632/oncotarget.11481

Table 2. Hazard ratio of CD81 adjusted on cytogenetic risk, age at diagnosis and NPM1+/FLT3-ITD- status.

HR (95% CI) P-value
EFS 3.45 (1.5-7.8) 0.003
OS 4.14 (1.69-10.14) 0.002
RFS 9.46 (2.66-33.71) 0.0005